Systematic review and meta-analysis of randomized controlled trials on safety and effectiveness of oral anticoagulants for atrial fibrillation in older people
G Erdem, M Esme, BB Doğu - Irish Journal of Medical Science (1971-), 2022 - Springer
A meta-analysis of prospective, randomized controlled trials on novel oral anticoagulants
(NOACs) versus warfarin, as most commonly used vitamin K antagonists (VKAs), was done …
(NOACs) versus warfarin, as most commonly used vitamin K antagonists (VKAs), was done …
Systematic review and meta-analysis of randomized controlled trials on safety and effectiveness of oral anticoagulants for atrial fibrillation in older people
G Erdem, M EŞME, B DOĞU - IRISH JOURNAL OF …, 2022 - avesis.hacettepe.edu.tr
A meta-analysis of prospective, randomized controlled trials on novel oral anticoagulants
(NOACs) versus warfarin, as most commonly used vitamin K antagonists (VKAs), was done …
(NOACs) versus warfarin, as most commonly used vitamin K antagonists (VKAs), was done …
Systematic review and meta-analysis of randomized controlled trials on safety and effectiveness of oral anticoagulants for atrial fibrillation in older people
G Erdem, M Esme, BB Doğu - 2022 - acikerisim.kent.edu.tr
A meta-analysis of prospective, randomized controlled trials on novel oral anticoagulants
(NOACs) versus warfarin, as most commonly used vitamin K antagonists (VKAs), was done …
(NOACs) versus warfarin, as most commonly used vitamin K antagonists (VKAs), was done …
Systematic review and meta-analysis of randomized controlled trials on safety and effectiveness of oral anticoagulants for atrial fibrillation in older people
G Erdem, M Esme, BB Doğu - Irish journal of medical …, 2022 - pubmed.ncbi.nlm.nih.gov
A meta-analysis of prospective, randomized controlled trials on novel oral anticoagulants
(NOACs) versus warfarin, as most commonly used vitamin K antagonists (VKAs), was done …
(NOACs) versus warfarin, as most commonly used vitamin K antagonists (VKAs), was done …
Systematic review and meta-analysis of randomized controlled trials on safety and effectiveness of oral anticoagulants for atrial fibrillation in older people.
G Erdem, M Esme, BB Doğu - Irish Journal of Medical Science, 2022 - europepmc.org
A meta-analysis of prospective, randomized controlled trials on novel oral anticoagulants
(NOACs) versus warfarin, as most commonly used vitamin K antagonists (VKAs), was done …
(NOACs) versus warfarin, as most commonly used vitamin K antagonists (VKAs), was done …